Active ingredients: pomalidomide
What it is used for
Pomalidomide, in combination with dexamethasone, is indicated for the treatment of patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
- The way to take this medicine: Oral
- Store below 25 degrees Celsius
- Store in Original Container
- Lifetime is 48 Months.
Always read the label. If symptoms persist see your healthcare professional.
Dark blue/orange size 2 gelatin capsules marked POML 2 mg in white ink
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Pregnant or planning a pregnancy?
For the active ingredient pomalidomide
This medicine is not considered safe during pregnancy. You should discuss this medicine with your doctor or pharmacist. They can help you balance the risks and the benefits of this medicine during pregnancy.
For side effects, taking other medicines and more
Download consumer medicine information leaflet (pdf)
Pomalyst Capsules - myDr.com.au
Pomalyst Capsules - Consumer Medicines Information leaflets of prescription and over-the-counter medicines
Read more on myDr – Consumer Medicine Information website
Diagnosis & Treatment for Kaposi Sarcoma - Cancer Council Victoria
Radiotherapy can be used to help get rid of the lesions. It works by killing the cancer cells with high-energy rays. Chemotherapy can also be used if there are Kaposi sarcoma lesions inside the body and you're having symptoms such as fever and weight loss.
Read more on Cancer Council Victoria website
Oral targeted therapy for cancer | Issue 5 | Volume 38 | Australian Prescriber
Oral targeted therapies are increasingly being used to treat cancer. They work by interfering with specific molecules or pathways involved in tumour...
Read more on Australian Prescriber website